1. Semaan MT, Megerian CA. The pathophysiology of cholesteatoma. Otolaryngol Clin North Am. 2006; 12. 39(6):1143–1159. PMID:
17097438.
Article
2. Louw L. Acquired cholesteatoma pathogenesis: stepwise explanations. J Laryngol Otol. 2010; 6. 124(6):587–593. PMID:
20156369.
Article
3. Shibosawa E, Tsutsumi K, Takakuwa T, Takahashi S. Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas. Am J Otol. 2000; 9. 21(5):621–624. PMID:
10993447.
4. Yilmaz T, Kocan EG, Besler HT, Yilmaz G, Gursel B. The role of oxidants and antioxidants in otitis media with effusion in children. Otolaryngol Head Neck Surg. 2004; 12. 131(6):797–803. PMID:
15577771.
Article
5. Karlidag T, Ilhan N, Kaygusuz I, Keles E, Yalcin S. Comparison of free radicals and antioxidant enzymes in chronic otitis media with and without tympanosclerosis. Laryngoscope. 2004; 1. 114(1):85–89. PMID:
14710000.
6. Döner F, Delibas N, Dogru H, Yariktas M, Demirci M. The role of free oxygen radicals in experimental otitis media. J Basic Clin Physiol Pharmacol. 2002; 13(1):33–40. PMID:
12099403.
Article
7. Aktan B, Gundogdu C, Ucuncu H, Unal B, Sutbeyaz Y, Altas S. Anti-inflammatory effect of erythromycin on histamine-induced otitis media with effusion in guinea pigs. J Laryngol Otol. 2004; 2. 118(2):97–101. PMID:
14979944.
Article
8. Hamzei M, Ventriglia G, Hagnia M, Antonopolous A, Bernal-Sprekelsen M, Dazert S, et al. Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope. 2003; 3. 113(3):436–442. PMID:
12616193.
Article
9. Chole RA, Faddis BT. Evidence for microbial biofilms in cholesteatomas. Arch Otolaryngol Head Neck Surg. 2002; 10. 128(10):1129–1133. PMID:
12365883.
Article
10. Peek FA, Huisman MA, Berckmans RJ, Sturk A, Van Loon J, Grote JJ. Lipopolysaccharide concentration and bone resorption in cholesteatoma. Otol Neurotol. 2003; 9. 24(5):709–713. PMID:
14501443.
Article
11. Baysal E, Aksoy N, Kara F, Taysi S, Taskin A, Bilinc H, et al. Oxidative stress in chronic otitis media. Eur Arch Otorhinolaryngol. 2013; 3. 270(4):1203–1208. PMID:
22711004.
Article
12. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39(1):44–84. PMID:
16978905.
Article
13. Shukla GK, Mahajan A, Pandey S, Gujrati VR, Vrat S, Mishra SC, et al. A study of free radicals and scavenging enzyme in tonsillitis. Boll Chim Farm. 1996; 12. 135(11):653–655. PMID:
9066174.
14. Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol. 1979; 10. 135(3):372–376. PMID:
484629.
Article
15. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem. 1989; 5. 179(1):8–18. PMID:
2547324.
Article
16. Aebi H. Catalase. In : Bergmayer HU, editor. Methods of enzymatic analysis. 2nd ed. New York: Academic Press Inc.;1974. p. 673–677.
17. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 7. 70(1):158–169. PMID:
6066618.
18. Babior BM. NADPH oxidase. Curr Opin Immunol. 2004; 2. 16(1):42–47. PMID:
14734109.
Article
19. Kavak S, Garca MF, Gecit I, Meral I, Cengiz N, Demir H. Effects of extracorporeal shock-wave lithotripsy directed at the parotid gland on oxidative stress parameters and some trace element levels in facial nerve of rats. Muscle Nerve. 2012; 4. 45(4):562–566. PMID:
22431090.
Article
20. Aslan M, Dogan S, Kucuksayan E. Oxidative stress and potential applications of free radical scavengers in glaucoma. Redox Rep. 2013; 18(2):76–87. PMID:
23485101.
Article
21. Soyoral YU, Aslan M, Emre H, Begenik H, Erdur FM, Turkel A, et al. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome. Atherosclerosis. 2011; 9. 218(1):243–246. PMID:
21723555.
Article
22. Aslan M, Cosar N, Celik H, Aksoy N, Dulger AC, Begenik H, et al. Evaluation of oxidative status in patients with hyperthyroidism. Endocrine. 2011; 10. 40(2):285–289. PMID:
21519910.
Article
23. Aslan M, Nazligu Y, Bolukbas C, Bolukbas FF, Horoz M, Dulger AC, et al. Peripheral lymphocyte DNA damage and oxidative stress in patients with ulcerative colitis. Pol Arch Med Wewn. 2011; Jul-Aug. 121(7-8):223–229. PMID:
21677607.
Article
24. Nazligul Y, Aslan M, Horoz M, Celik Y, Dulger AC, Celik H, et al. The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected. Clin Biochem. 2011; 6. 44(8-9):647–649. PMID:
21396358.
Article
25. Parks RR, Huang CC, Haddad J Jr. Evidence of oxygen radical injury in experimental otitis media. Laryngoscope. 1994; 11. 104(11 Pt 1):1389–1392. PMID:
7968170.
Article
26. Shigemi H, Egashira T, Kurono Y, Mogi G. Role of superoxide dismutase in otitis media with effusion. Ann Otol Rhinol Laryngol. 1998; 4. 107(4):327–331. PMID:
9557768.
Article
27. Yariktas M, Doner F, Dogru H, Yasan H, Delibas N. The role of free oxygen radicals on the development of otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2004; 7. 68(7):889–894. PMID:
15183579.
Article
28. Aktan B, Taysi S, Gumustekin K, Bakan N, Sutbeyaz Y. Evaluation of oxidative stress in erythrocytes of guinea pigs with experimental otitis media and effusion. Ann Clin Lab Sci. 2003; Spring. 33(2):232–236. PMID:
12817629.
29. Khakimov AM, Arifov SS, Faizulaeva FN. Efficacy of antioxidant therapy in patients with acute and chronic purulent otitis media. Vestn Otorinolaringol. 1997; (5):16–19. PMID:
9432764.
30. Garcia Callejo FJ, Estors Ferrero J, Morant Ventura A, Segarra Cortes P, Velert Vila MM. Lipoperoxidation in otorrhea of the middle ear as a marker of infection: clinical application. Acta Otorrinolaringol Esp. 2000; Aug-Sep. 51(6):478–481. PMID:
11142782.